Other News To Note
Friday, August 26, 2011
Oxygen Biotherapeutics Inc., of Morrisville, N.C., dismissed Chris Stern as CEO and chairman of the company, following an internal investigation. Although the circumstances related to the dismissal were not disclosed, the company said Stern will not be paid severance. Michael Jebsen was named interim CEO as he continues serving as chief financial officer and treasurer.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.